Načítá se...
Advances in the Management of Treatment-Resistant Depression
Treatment-resistant depression (TRD) is a prevalent, disabling, and costly condition affecting 1%–4% of the U.S. population. Current approaches to managing TRD include medication augmentation (with lithium, thyroid hormone, buspirone, atypical antipsychotics, or various antidepressant medications),...
Uloženo v:
| Vydáno v: | Focus (Am Psychiatr Publ) |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4423609/ https://ncbi.nlm.nih.gov/pubmed/25960694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/foc.8.4.foc488 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|